Jim Fearnside

Title: Jim Fearnside and Ultrasound Monitoring for Sono-Thrombolysis

Introduction

Jim Fearnside is an inventor associated with Lexington, Massachusetts, and Walnut Technologies. His patent work addresses real-time monitoring and control during sono-thrombolysis therapy, an approach that uses ultrasound in treating thrombotic or embolic occlusions.

Latest Patents

The provided information lists one patent for Fearnside: “Ultrasound Signal and Temperature Monitoring During Sono-Thrombolysis Therapy.” The invention describes a system and method that monitor ultrasound intensity and temperature continuously while ultrasound is delivered to an occlusion. The system uses an ultrasound transducer, a coupling medium, and a hydrophone to deliver and monitor the ultrasound signal. It also monitors temperature near the treatment site in real time. Based on the measured ultrasound characteristics, the system adjusts the delivered intensity to keep it within a desired range. Fearnside is credited with 1 patent.

Career Highlights

Fearnside’s listed patent focuses on monitoring treatment conditions during ultrasound therapy. By combining real-time signal measurement with temperature monitoring and intensity control, the invention is designed to help maintain specified operating conditions during sono-thrombolysis.

Collaborations

The supplied information identifies Walnut Technologies as Fearnside’s company and Al Kyle as his coworker. No further details about their roles or collaboration are provided.

Conclusion

Jim Fearnside’s listed invention brings together ultrasound monitoring, temperature measurement, and intensity control for sono-thrombolysis therapy.